Le Lézard
Classified in: Health, Science and technology, Business
Subject: FNC

Aequum Capital Provides $7.5MM Asset-Based Revolver to Midwest Based Specialty Online Pharmacy


CHICAGO, Dec. 8, 2022 /PRNewswire/ -- Aequum Capital is pleased to announce it recently closed a $7,500,000 credit facility to a Midwest based industry-leading technology focused independent online pharmacy. The Company primarily serves the specialty pharmaceutical market and provides better access to specialty medications that are harder to access at large chains.  Aequum provided a unique solution that allows the Company to access additional capital to support their growth initiatives.  The loan increased its current revolving asset-based facility and will assist the Company with its working capital needs and support future growth.

Aequum Capital Financial is a tech-enabled, ESG-focused specialty finance lender providing senior asset-backed and cash flow debt facilities to small and medium-sized businesses throughout the U.S., ranging between $1MM and $10MM. 

For more information, please go to https://aequumcapital.com

SOURCE Aequum Capital Financial LLC


These press releases may also interest you

at 11:15
Variantyx, a leader in molecular diagnostics, announced today that it has secured an additional $36 million in funding from its portfolio of investors which includes Peregrine Ventures, Pitango HealthTech, New Era Capital Partners and Bosch Ventures....

at 11:03
The heart of Vajra Coffee's natural decaffeination process lies in its adoption of the Swiss Water® Process, a natural method that removes 99% of caffeine...

at 11:00
United Imaging Healthcare (SSE:688271) has published its 2023 Environment, Social, and Governance (ESG) Report, reaffirming its mission to bring Equal Healthcare for All. This report highlights the company's advancements in corporate responsibility,...

at 11:00
United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023,...

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...



News published on and distributed by: